[en] We describe a simple method for the detection of biotinidase Km-variants and detailed biochemical investigations in 5 such patient. They were detected among 103 patients with plasma biotinidase activity which ranged from undetectable to 30% of the mean normal value. Two different types of biotinidase Km-variants were found. (1) In 3 infants biotinidase had a single 105-430-fold elevated Km for biocytin. Biotinidase showed very low activities (0.2-4% of the mean normal value) in the routine colorimetric assay and was not functional in vivo. Accordingly, these patients presented with classical clinical illness. (2) In two patients biotinidase showed biphasic kinetics indicating the presence of one component with a normal Km and reduced Vmax (1.7% and 12%), and another with 330- and 59-fold elevated Km, respectively. In these two patients, biotinidase proved to be at least partially functional in vivo. However, the first patient developed severe symptoms and biotin deficiency late, at the age of 10-15 years, and the second had marginal biotin deficiency at the age of 2 years but no clinical symptoms. Comparative studies revealed that both patients had more severe biotin deficiency than age-matched patients with similar levels of residual biotinidase activity and a single normal Km. Therefore, all patients with residual biotinidase activity should be evaluated for the presence of a Km-mutation, since such patients should be treated with biotin. These can easily be detected by including a second substrate concentration (1.5 mmol/L) in the routine colorimetric biotinidase assay which is performed with 0.15 mmol/L biotin. Increased activity with the higher substrate concentration indicates the presence of a Km-mutation. Detailed kinetic studies are needed to evaluate the distinct forms of Km-variants.
Disciplines :
Pediatrics Neurology
Author, co-author :
Suormala, T.; Metabolic Unit, University Children's Hospital, Basel, Switzerland
RAMAEKERS, Vincent ; Department of Pediatrics and Ophthalmology, Technical University of Aachen
Schweitzer, S.; Children's Hospital, Medical School Hannover, Hannover
Fowler, B.; Metabolic Unit, University Children's Hospital, Basel, Switzerland
Laub, M. C.; Neuropediatric Department, Behandlungszentrum Vogtareuth, Vogtareuth
Schwermer, C.; 5Department of Pediatrics, City Hospital, Krefeld
Bachmann, J.; Department of Pediatrics, Central Hospital North Bremen, Bremen, Germany
Baumgartner, E. R.; Metabolic Unit, University Children's Hospital, Basel, Switzerland
Language :
English
Title :
Biotinidase Km-variants: detection and detailed biochemical investigations
Baumgartner E.R., Suormala T.M., Wick H. (1989) Biotinidase deficiency: a cause of subacute necrotizing encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome. Pediatr Res 26:260-266.
Diamantopoulos N., Painter M.J., Wolf B., Heard G.S., Roe C. (1986) Biotinidase deficiency: accumulation of lactate in the brain and response to physiological doses of biotin. Neurology 36:1107-1109.
Duran M., Baumgartner E.R., Suormala T. (1993) Cerebrospinal fluid organic acids in biotinidase deficiency. J Inher Metab Dis 16:513-516.
Guardabasso V., Benfenati F. (1983) A simple method to determine binding parameters in a two-site case using linear regression. Computer Programs in Biomedicine 17:235-242.
Heard G.S., Wolf B., Jefferson L.G. (1986) Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. J Pediatr 108:40-46.
Knappe J., Brümmer W., Biederbick K. (1963) Reinigung und Eigenschaften der Biotinidase aus Schweinenieren und Lactobacillus casei. Biochem J 338:599-613.
Leighton F., Poole B., Beaufay H. (1968) The large-scale separation of peroxisomes, mitochondria and lysosomes from the liver of rats injected with Triton WR-1339. J Cell Biol 37:482-513.
Ramaekers V.TH, Suormala T.M., Brab M., Duran M., Heimann G., Baumgartner E.R. (1992) A biotinidase Km variant causing late onset bilateral optic neuropathy. Arch Dis Child 67:115-119.
Schweitzer S., Sander J., Suormala T., Baumgartner E.R., Byrd D., Brodehl J. (1991) Der Biotinidasemangel: Ergebnisse des Neugeborenen-Screenings 1985–1989 in Niedersachsen. Monatsschr Kinderheilkd 139:349-354.
Suormala T., Wick H., Bonjour J.P., Baumgartner E.R. (1985) Rapid differential diagnosis of carboxylase deficiencies and evaluation of biotin responsiveness in a single blood sample. Clin Chim Acta 145:151-162.
Suormala T.M., Baumgartner E.R., Bausch J., Holick W., Wick H. (1988) Quantitative determination of biocytin in urine of patients with biotinidase deficiency using high-performance liquid chromatography (HPLC). Clin Chim Acta 177:253-270.
Suormala T.M., Baumgartner E.R., Wick H., Scheibenreiter S., Schweitzer S. (1990) Comparison of patients with complete and partial biotinidase deficiency: biochemical studies. J Inher Metab Dis 13:76-92.
Wastell H.J., Bartlett K., Dale G., Shein A. (1988) Biotinidase deficiency: a survey of 10 cases. Arch Dis Child 63:1244-1249.
Wolf B. (1991) Worldwide survey of neonatal screening for biotinidase deficiency. J Inher Metab Dis 14:923-927.
Wolf B., Grier R.E., Allen R.J., Goodman S.I., Kien C.L. (1983) Biotinidase deficiency: enzymatic defect in late-onset multiple carboxylase deficiency. Clin Chim Acta 131:273-281.
Wolf B., Heard G.S., Jefferson L.G., Proud V.K., Nance W.E., Weissbecker K.A. (1985) Clinical findings in four children with biotinidase deficiency detected through a state-wide neonatal screening program. N Engl J Med 313:16-19.
Wolf B., Heard G.S., Weissbecker K.A., Secor McVoy J., Grier R.E., Leshner R.T. (1985) Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol 18:614-617.